BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33597592)

  • 41. [Investigation of E6/E7 mRNAs of high risk human papilloma virus types by a commercial automatized NASBA assay in cervical swabs].
    Ardiç N; Oztürk O; Ergünay K; Sezer O
    Mikrobiyol Bul; 2009 Jul; 43(3):463-9. PubMed ID: 19795622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of human papillomavirus in lung tumor tissue.
    Koshiol J; Rotunno M; Gillison ML; Van Doorn LJ; Chaturvedi AK; Tarantini L; Song H; Quint WG; Struijk L; Goldstein AM; Hildesheim A; Taylor PR; Wacholder S; Bertazzi PA; Landi MT; Caporaso NE
    J Natl Cancer Inst; 2011 Mar; 103(6):501-7. PubMed ID: 21293027
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An Isothermal, Multiplex Amplification Assay for Detection and Genotyping of Human Papillomaviruses in Formalin-Fixed, Paraffin-Embedded Tissues.
    Tang YW; Lozano L; Chen X; Querec TD; Katabi N; Moreno-Docón A; Wang H; Fix D; De Brot L; McMillen TA; Yoon JY; Torroba A; Wang Y; Unger ER; Park KJ
    J Mol Diagn; 2020 Mar; 22(3):419-428. PubMed ID: 31978559
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Salivary mucoepidermoid carcinoma: demonstration of transcriptionally active human papillomavirus 16/18.
    Isayeva T; Said-Al-Naief N; Ren Z; Li R; Gnepp D; Brandwein-Gensler M
    Head Neck Pathol; 2013 Jun; 7(2):135-48. PubMed ID: 23233027
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biplex quantitative PCR to detect transcriptionally active human papillomavirus 16 from patient saliva.
    Deutsch F; Sais D; Keatinge N; Hill M; Tran NH; Elliott M; Tran N
    BMC Cancer; 2024 Apr; 24(1):442. PubMed ID: 38600473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia.
    Zumbach K; Kisseljov F; Sacharova O; Shaichaev G; Semjonova L; Pavlova L; Pawlita M
    Int J Cancer; 2000 Feb; 85(3):313-8. PubMed ID: 10652419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The E2F5 repressor is an activator of E6/E7 transcription and of the S-phase entry in HPV18-associated cells.
    Teissier S; Pang CL; Thierry F
    Oncogene; 2010 Sep; 29(36):5061-70. PubMed ID: 20639900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials.
    Jordan RC; Lingen MW; Perez-Ordonez B; He X; Pickard R; Koluder M; Jiang B; Wakely P; Xiao W; Gillison ML
    Am J Surg Pathol; 2012 Jul; 36(7):945-54. PubMed ID: 22743284
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells.
    Rampias T; Boutati E; Pectasides E; Sasaki C; Kountourakis P; Weinberger P; Psyrri A
    Mol Cancer Res; 2010 Mar; 8(3):433-43. PubMed ID: 20215420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
    Hu Z; Ding W; Zhu D; Yu L; Jiang X; Wang X; Zhang C; Wang L; Ji T; Liu D; He D; Xia X; Zhu T; Wei J; Wu P; Wang C; Xi L; Gao Q; Chen G; Liu R; Li K; Li S; Wang S; Zhou J; Ma D; Wang H
    J Clin Invest; 2015 Jan; 125(1):425-36. PubMed ID: 25500889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.
    Ndiaye C; Mena M; Alemany L; Arbyn M; Castellsagué X; Laporte L; Bosch FX; de Sanjosé S; Trottier H
    Lancet Oncol; 2014 Nov; 15(12):1319-31. PubMed ID: 25439690
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings.
    Tezcan S; Ozgur D; Ulger M; Aslan G; Gurses I; Serin MS; Giray BG; Dilek S; Emekdas G
    Asian Pac J Cancer Prev; 2014; 15(9):3997-4003. PubMed ID: 24935586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. E6/E7 mRNA expression of high-risk HPV types in 849 Greek women.
    Argyri E; Tsimplaki E; Daskalopoulou D; Stravopodis DJ; Kouikoglou O; Terzakis E; Panotopoulou E
    Anticancer Res; 2013 Sep; 33(9):4007-11. PubMed ID: 24023342
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clinical application of HPV E6/E7 mRNA testing in triaging women with atypical squamous cells of undetermined significance or low-grade squamous intra-epithelial lesion Pap smear: A meta-analysis.
    Yang L; Zhu Y; Bai Y; Zhang X; Ren C
    J Cancer Res Ther; 2017; 13(4):613-620. PubMed ID: 28901302
    [TBL] [Abstract][Full Text] [Related]  

  • 55. RPRD1B is a potentially molecular target for diagnosis and prevention of human papillomavirus E6/E7 infection-induced cervical cancer: A case-control study.
    Wen N; Bian L; Gon J; Meng Y
    Asia Pac J Clin Oncol; 2021 Jun; 17(3):230-237. PubMed ID: 32866332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis.
    Masterson L; Winder DM; Ball SL; Vaughan K; Lehmann M; Scholtz LU; Sterling JC; Sudhoff HH; Goon PK
    BMC Cancer; 2016 Jun; 16():367. PubMed ID: 27296171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical performance of the PreTect HPV-Proofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer.
    Ratnam S; Coutlee F; Fontaine D; Bentley J; Escott N; Ghatage P; Gadag V; Holloway G; Bartellas E; Kum N; Giede C; Lear A
    J Clin Microbiol; 2010 Aug; 48(8):2779-85. PubMed ID: 20573862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with the linear array HPV genotyping PCR assay and influence of DNA extraction method on HPV detection.
    Roberts CC; Swoyer R; Bryan JT; Taddeo FJ
    J Clin Microbiol; 2011 May; 49(5):1899-906. PubMed ID: 21346041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MiR-122 directly inhibits human papillomavirus E6 gene and enhances interferon signaling through blocking suppressor of cytokine signaling 1 in SiHa cells.
    He J; Ji Y; Li A; Zhang Q; Song W; Li Y; Huang H; Qian J; Zhai A; Yu X; Zhao J; Shang Q; Wei L; Zhang F
    PLoS One; 2014; 9(9):e108410. PubMed ID: 25265013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
    Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
    J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.